The global consumer goods conglomerate Procter & Gamble (P&G) Health Ltd dropped more than 5% in morning trade on Thursday, August 24, after the company reported poor numbers for the fourth quarter ending June 2023 (Q4FY23).

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

The quarterly earnings report showed mixed results as the company's revenue increased marginally and net profit as well as EBITDA (earnings before interest, taxes, depreciation, and amortisation) dropped.

P&G Health’s PAT and EBITDA drop in June quarter

The company reported total revenue of Rs 301 crore, showing a modest increase of 1.6 per cent year-on-year compared to Rs 296 crore reported in the corresponding quarter a year ago. However, this increase in revenue was not mirrored in all aspects of the financial report.

The company’s EBITDA dropped 23.7 per cent to Rs 45 crore YoY from Rs 59 crore reported in the same quarter in the preceding financial year.

This decline in EBITDA was further reflected in the operating margins as well, which stood at 14.9 per cent compared to 19.9 per cent a year ago. 

The FMCG conglomerate’s profit after tax (PAT) also showed a decline at Rs 30 crore, down 26.8 per cent compared to Rs  41 crore during the same quarter in the previous fiscal.

Other expenses were reported at Rs 107 crore, slightly higher than the Rs 105 crore during the same period a year ago. Additionally, the employee benefit expenses showed a notable increase, rising to Rs 55.4 crore from Rs 42.1 crore on a year-on-year basis. An interesting addition to these expenses is the tax for earlier years amounting to Rs 3.1 crore, which was accounted for in this quarter's results.

P&G Health declares dividend

Despite the mixed performance results, P&G has not deterred from making positive overtures to its investors. The company has announced a final dividend of Rs 50 per share for the Financial Year ending June 30, 2023. The FMCG giant said that considering the interim dividend of Rs 45 per share declared earlier the total dividend payout for the financial year will be Rs 95 per share.

Shares of P&G Health Ltd were trading 4.21 per cent lower at Rs 5,110 apiece on BSE at 12:39 PM.